● Recruiting

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

Condition: Non-segmental Vitiligo · Sponsor: Novartis Pharmaceuticals

PhasePhase 2

Planned participants210

Who can joinAll sexes, 18 Years to 99 Years

Healthy volunteersNo

About this study

The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optimal dose to be promoted into the confirmatory Phase 3 program.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (52)

Cahaba Derm and skin hlth ctr 27	Birmingham, Alabama, United States	Recruiting
First OC Dermatology	Fountain Valley, California, United States	Recruiting
MedDerm Associates	San Diego, California, United States	Recruiting
Clinical Trials Research Institute	Thousand Oaks, California, United States	Recruiting
Encore Medical Research	Hollywood, Florida, United States	Recruiting
Mayo Clinic Jacksonville	Jacksonville, Florida, United States	Recruiting
Miami Derm and Laser Institute	Miami, Florida, United States	Recruiting
Global Clinical Professionals	St. Petersburg, Florida, United States	Recruiting
Dawes Fretzin Clinical Rea Group	Indianapolis, Indiana, United States	Recruiting
Hamzavi Dermatology	Fort Gratiot, Michigan, United States	Recruiting
Revival Research Institute	Troy, Michigan, United States	Recruiting
Skin Specialists PC	Omaha, Nebraska, United States	Recruiting

+ 40 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07431177